Brave Warrior Advisors LLC Reduces Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Brave Warrior Advisors LLC reduced its stake in HCA Healthcare by 43.0%, holding 1,923 shares valued at $664,000 as of its latest SEC filing.
• HCA Healthcare reported $6.84 earnings per share (EPS) for the quarter, exceeding analysts' expectations, with a revenue increase of 6.4% year-over-year.
• The company declared a quarterly dividend of $0.72 per share, with a dividend yield of 0.7%, marking a payout ratio of 12.11%.

Brave Warrior Advisors LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 43.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,923 shares of the company's stock after selling 1,450 shares during the period. HCA Healthcare makes up approximately 0.0% of Brave Warrior Advisors LLC's portfolio, making the stock its 23rd biggest position. Brave Warrior Advisors LLC's holdings in HCA Healthcare were worth $664,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD increased its position in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after buying an additional 1,091,416 shares in the last quarter. Nuveen Asset Management LLC increased its position in HCA Healthcare by 4.5% in the 4th quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company's stock valued at $560,011,000 after buying an additional 81,105 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after purchasing an additional 587,036 shares in the last quarter. GAMMA Investing LLC increased its holdings in HCA Healthcare by 40,527.3% during the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after purchasing an additional 1,699,713 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in HCA Healthcare by 12.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,675,460 shares of the company's stock worth $502,889,000 after purchasing an additional 188,093 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have commented on HCA shares. Stephens raised HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Royal Bank Of Canada cut their target price on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Robert W. Baird boosted their target price on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Finally, Wells Fargo & Company cut their target price on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the company's stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and an average price target of $401.83.

HCA Healthcare Stock Performance

HCA Healthcare stock traded up $9.09 during trading on Friday, hitting $420.68. The stock had a trading volume of 1,059,770 shares, compared to its average volume of 1,054,336. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $420.98. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The stock's 50 day moving average is $380.14 and its two-hundred day moving average is $359.85. The stock has a market cap of $98.44 billion, a price-to-earnings ratio of 17.68, a price-to-earnings-growth ratio of 1.29 and a beta of 1.41.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the prior year, the business earned $5.50 earnings per share. HCA Healthcare's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.